Changes in the TCRβ Repertoire and Tumor Immune Signature From a Cutaneous Melanoma Patient Immunized With the CSF-470 Vaccine: A Case Report.

Autor: Aris, Mariana, Bravo, Alicia Inés, Pampena, María Betina, Blanco, Paula Alejandra, Carri, Ibel, Koile, Daniel, Yankilevich, Patricio, Levy, Estrella Mariel, Barrio, María Marcela, Mordoh, José

Publikováno v: Frontiers in Immunology; 5/3/2018, p1-N.PAG, 9p

Immunization With the CSF-470 Vaccine Plus BCG and rhGM-CSF Induced in a Cutaneous Melanoma Patient a TCRβ Repertoire Found at Vaccination Site and Tumor Infiltrating Lymphocytes That Persisted in Blood

Autor: Mariana Aris, Alicia Inés Bravo, Heli Magalí Garcia Alvarez, Ibel Carri, Enrique Podaza, Paula Alejandra Blanco, Cecilia Rotondaro, Sofia Bentivegna, Morten Nielsen, María Marcela Barrio, José Mordoh

Publikováno v: Frontiers in Immunology
Aris, M, Bravo, A I, Garcia Alvarez, H M, Carri, I, Podaza, E, Blanco, P A, Rotondaro, C, Bentivegna, S, Nielsen, M, Barrio, M M & Mordoh, J 2019, ' Immunization With the CSF-470 Vaccine Plus BCG and rhGM-CSF Induced in a Cutaneous Melanoma Patient a TCRβ Repertoire Found at Vaccination Site and Tumor Infiltrating Lymphocytes That Persisted in Blood ', Frontiers in Immunology, vol. 10, 2213 . https://doi.org/10.3389/fimmu.2019.02213
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Frontiers in Immunology, Vol 10 (2019)

The CSF-470 cellular vaccine plus BCG and rhGM-CSF increased distant metastases-free survival in cutaneous melanoma patients stages IIB-IIC-III relative to medium dose IFN-α2b (CASVAC-0401 study). Patient-045 developed a mature vaccination site (VAC

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b80ab07ab0608d87432f7f32d129029
http://europepmc.org/articles/PMC6759869

Phase II Study of Adjuvant Immunotherapy with the CSF-470 Vaccine Plus Bacillus Calmette–Guerin Plus Recombinant Human Granulocyte Macrophage-Colony Stimulating Factor vs Medium-Dose Interferon Alpha 2B in Stages IIB, IIC, and III Cutaneous Melanoma Patients: A Single Institution, Randomized Study

Autor: José Mordoh, María Betina Pampena, Mariana Aris, Paula Alejandra Blanco, Mónica Lombardo, Erika María von Euw, Soledad Mac Keon, Michelle Yépez Crow, Alicia Inés Bravo, Juan Manuel O’Connor, Ana Gabriela Orlando, Franco Ramello, Estrella Mariel Levy, María Marcela Barrio

Publikováno v: Frontiers in Immunology
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Frontiers in Immunology, Vol 8 (2017)

The irradiated, allogeneic, cellular CSF-470 vaccine plus Bacillus Calmette-Guerin (BCG) and recombinant human granulocyte macrophage-colony stimulating factor (rhGM-CSF) is being tested against medium-dose IFN-α2b in stages IIB-III cutaneous melano

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6c1770160546b42d969ce0f37cd24dd